ICEPHARMA A/S: Financial statements 2018
CVR: 36393459
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ICEPHARMA A/S (CVR 36393459) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -3,628,386 and a net result of DKK -7,235,141 compared with DKK -4,846,949 the year before. Equity in the 2018 report amounted to DKK 828,645. The solvency ratio was 39.2%. The company had 5 employees in the financial year.
- Gross Profit
- DKK -3,628,386
- Profit/Loss
- DKK -7,235,141
- Equity
- DKK 828,645
- Total Assets
- DKK 2,113,271
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -3.6 mio. | -7.2 mio. | 829 t. | 5 |
| 2017 | - | -722 t. | -4.8 mio. | -579 t. | 6 |
| 2016 | - | 2.2 mio. | -3.8 mio. | 188 t. | 5 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
ICEPHARMA A/S has published its annual report for 2017. Gross profit came to DKK -721,994, and the net result was DKK -4,846,949.
About ICEPHARMA A/S
ICEPHARMA A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Hörður Þórhallsson. The board consists of Kristján Johannsson (chair), Jóhann Ingi Kristjánsson and Petrea Ingileif Gudmundsdottir. The company is owned by Eignarhaldsfélagið Lyng ehf. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,000,033 and a net result of DKK 1,883,876 compared with DKK -3,562,543 the year before. Equity in the 2025 report amounted to DKK 10,304,500.